Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. [electronic resource]
Producer: 20131126Description: 150-6 p. digitalISSN:- 1538-2443
- AIDS Dementia Complex -- blood
- Adult
- Age Factors
- Anti-Retroviral Agents -- therapeutic use
- Antiretroviral Therapy, Highly Active
- Apolipoprotein E4 -- blood
- Asymptomatic Diseases
- CD4 Lymphocyte Count
- Cross-Sectional Studies
- Female
- Gene Dosage
- Genotype
- Humans
- Logistic Models
- Male
- Middle Aged
- Neuropsychological Tests
- Risk Factors
- Severity of Illness Index
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.